The Schall Law Firm: Seeking Shareholder Contributions for Securities Fraud Case Against Dentsply Sirona Inc.

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against DENTSPLY SIRONA Inc. Los Angeles, CA / ACCESSWIRE / December 26, 2024 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DENTSPLY SIRONA Inc. (“Dentsply” or “the Company”) (NASDAQ:XRAY) for violations of 10(b) and 20(a)…

Read More

Join the Fight Against Securities Fraud: The Schall Law Firm Calls for Investor Support in Case Against ASP Isotopes Inc.

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against ASP Isotopes Inc. LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 Overview The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. (“ASP Isotopes” or “the Company”) (NASDAQ:ASPI) for violations of 10(b)…

Read More

Take Action: Rentokil Initial PLC Faces Lawsuit for Securities Law Breaches – Reach Out to The Schall Law Firm for Support

Investors Beware: Class Action Lawsuit Against Rentokil Initial plc December 26, 2024 Recently, The Schall Law Firm issued a reminder to investors regarding a class action lawsuit against Rentokil Initial plc for alleged violations of federal securities laws. The lawsuit accuses Rentokil of violating 10(b) and 20(a) of the Securities Exchange Act of 1934 and…

Read More

Breaking Down the Latest Crypto Regulations: What You Need to Know!

Japan Faces Uncertainty on Bitcoin Reserve Decision The Confusion Continues Recently, Japan’s Prime Minister Shigeru Ishiba raised concerns about adopting Bitcoin reserves, stating that his government lacks adequate information on global strategies, including moves in the United States. This has left the country in a state of uncertainty when it comes to making a decision…

Read More

An Investigation Has Commenced on Behalf of Keros Therapeutics Inc. Shareholders: Contact Levi & Korsinsky to Discuss Your KROS Losses

Levi & Korsinsky Investigates Keros Therapeutics, Inc. for Securities Violations New York, NY / Accesswire / December 26, 2024 / Levi & Korsinsky has initiated an investigation into Keros Therapeutics, Inc. (NASDAQ:KROS) for possible violations of federal securities laws. This comes after Keros issued a press release on December 12, 2024, regarding a safety review…

Read More